Mutation of GATA3 in human breast tumors
- PMID: 15361840
- DOI: 10.1038/sj.onc.1207966
Mutation of GATA3 in human breast tumors
Abstract
GATA3 is an essential transcription factor that was first identified as a regulator of immune cell function. In recent microarray analyses of human breast tumors, both normal breast luminal epithelium and estrogen receptor (ESR1)-positive tumors showed high expression of GATA3. We sequenced genomic DNA from 111 breast tumors and three breast-tumor-derived cell lines and identified somatic mutations of GATA3 in five tumors and the MCF-7 cell line. These mutations cluster in the vicinity of the highly conserved second zinc-finger that is required for DNA binding. In addition to these five, we identified using cDNA sequencing a unique mis-splicing variant that caused a frameshift mutation. One of the somatic mutations we identified was identical to a germline GATA3 mutation reported in two kindreds with HDR syndrome/OMIM #146255, which is an autosomal dominant syndrome caused by the haplo-insufficiency of GATA3. The ectopic expression of GATA3 in human 293T cells caused the induction of 73 genes including six cytokeratins, and inhibited cell line doubling times. These data suggest that GATA3 is involved in growth control and the maintenance of the differentiated state in epithelial cells, and that GATA3 variants may contribute to tumorigenesis in ESR1-positive breast tumors.
Similar articles
-
GATA3 haplo-insufficiency causes human HDR syndrome.Nature. 2000 Jul 27;406(6794):419-22. doi: 10.1038/35019088. Nature. 2000. PMID: 10935639
-
Structure and expression of the human GATA3 gene.Genomics. 1994 May 1;21(1):1-6. doi: 10.1006/geno.1994.1217. Genomics. 1994. PMID: 8088776
-
Identification of a novel insertion mutation in GATA3 with HDR syndrome.Clin Exp Nephrol. 2005 Mar;9(1):58-61. doi: 10.1007/s10157-004-0327-6. Clin Exp Nephrol. 2005. PMID: 15830275
-
The Significance and Therapeutic Potential of GATA3 Expression and Mutation in Breast Cancer: A Systematic Review.Med Res Rev. 2015 Nov;35(6):1300-15. doi: 10.1002/med.21362. Epub 2015 Aug 27. Med Res Rev. 2015. PMID: 26313026 Review.
-
GATA3 in Breast Cancer: Tumor Suppressor or Oncogene?Gene Expr. 2015;16(4):163-8. doi: 10.3727/105221615X14399878166113. Gene Expr. 2015. PMID: 26637396 Free PMC article. Review.
Cited by
-
Linking patient outcome to high throughput protein expression data identifies novel regulators of colorectal adenocarcinoma aggressiveness.F1000Res. 2015 Apr 24;4:99. doi: 10.12688/f1000research.6388.1. eCollection 2015. F1000Res. 2015. PMID: 26097693 Free PMC article.
-
GATA3 acts upstream of FOXA1 in mediating ESR1 binding by shaping enhancer accessibility.Genome Res. 2013 Jan;23(1):12-22. doi: 10.1101/gr.139469.112. Epub 2012 Nov 21. Genome Res. 2013. PMID: 23172872 Free PMC article.
-
Association of GATA3 Polymorphisms With Minimal Residual Disease and Relapse Risk in Childhood Acute Lymphoblastic Leukemia.J Natl Cancer Inst. 2021 Apr 6;113(4):408-417. doi: 10.1093/jnci/djaa138. J Natl Cancer Inst. 2021. PMID: 32894760 Free PMC article. Clinical Trial.
-
Structural and conformational changes induced by missense variants in the zinc finger domains of GATA3 involved in breast cancer.RSC Adv. 2020 Oct 29;10(65):39640-39653. doi: 10.1039/d0ra07786k. eCollection 2020 Oct 27. RSC Adv. 2020. PMID: 35515377 Free PMC article.
-
NCR-PCOPGene: An Exploratory Tool for Analysis of Sample-Classes Effect on Gene-Expression Relationships.Adv Bioinformatics. 2008;2008:789026. doi: 10.1155/2008/789026. Epub 2008 Dec 10. Adv Bioinformatics. 2008. PMID: 19920990 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous